Ultima-ACE-031 1mg – 1 vial x 1mg – UltimaPeptides USA is a synthetic myostatin inhibitor peptide designed to promote muscle mass gain and improve recovery. It works by blocking a natural protein in the body called myostatin, which is a powerful inhibitor of muscle growth. When myostatin is blocked, your muscles can grow and become stronger than they normally would.
Ultima-ACE-031 1mg – 1 vial x 1mg – UltimaPeptides USA
$109
Description
ACE-031 is created by combining fragments of two human proteins: one that normally binds to myostatin, and the other that helps myostatin remain active longer in the body. Together, they act as a trap, capturing myostatin before it can exert its effect. This not only helps increase lean muscle mass but also promotes bone strength.
It was initially developed to treat serious diseases causing muscle wasting, such as Duchenne muscular dystrophy and age-related muscle damage. Preliminary research has shown great promise in stimulating muscle growth. Although its clinical development was put on hold due to some mild side effects, ACE-031 continues to play an important role in ongoing research and has generated significant interest in the fitness world for its potential to improve performance and recovery.
- Our Warehouse Ultima is shipping in the USA (New York, Los Angeles, Florida, North-Carolina, Texasβ¦)
- Brands available from our Warehouse USA ULTIMA : Ultima Pharma
- Shipping cost for this warehouse = $19 (+15% of total order amount if you select our insurance)
- It takes usually less than 24 β 48 hours (except weekend) after your order is paid to ship.
- After shipped, delivery in 7 to 10 days.
- Shipping tracking number is sent to you after 3 days.
- We give particular attention to the packaging and delivery of all your products. Each shipment is treated with the utmost care. Our products are vacuum sealed to ensure protection, sterility, and especially incomparable discretion. We ship the products with their original packaging and instructions.



Reviews
There are no reviews yet.